Published in

Elsevier, Annals of Oncology, 2(30), p. 297-302, 2019

DOI: 10.1093/annonc/mdy522

Elsevier, Annals of Oncology, 10(30), p. 1673, 2019

DOI: 10.1093/annonc/mdz171

Links

Tools

Export citation

Search in Google Scholar

OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO